Addressing Emotional and Cognitive Factors in Behavioral Weight Loss Treatment (Part 2)
NCT ID: NCT00558194
Last Updated: 2018-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2009-08-31
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Addressing Emotional and Cognitive Factors in Behavioral Weight Loss Treatment
NCT00533052
Cognitive-behavioral Weight Loss Treatment
NCT01693913
Computer Intervention for Prevention of Weight Regain
NCT00067145
Remote Delivery of Weight Management for Adults With IDD
NCT03291509
Behavioral Treatment for Weight Loss
NCT00746265
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Standard behavioral weight loss treatment with cognitive and affective skills training
Standard Behavioral Weight Loss Treatment with Affective and Cognitive Skills Training
12-month (6-month weekly, 3-month biweekly, 3-month monthly) group treatment
2
Standard behavioral weight loss treatment
Standard Behavioral Weight Loss Treatment
12-month (6-month weekly, 3-month biweekly, 3-month monthly) group treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard Behavioral Weight Loss Treatment with Affective and Cognitive Skills Training
12-month (6-month weekly, 3-month biweekly, 3-month monthly) group treatment
Standard Behavioral Weight Loss Treatment
12-month (6-month weekly, 3-month biweekly, 3-month monthly) group treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index between 27 and 40
* Score 5 or above on the internal disinhibition scale of the Eating Inventory
Exclusion Criteria
* Are pregnant, lactating, less than 6 months postpartum or plan to become pregnant during the time frame of the investigation
* Report a heart condition, chest pain during periods of activity or rest, or loss of consciousness on the Physical Activity Readiness Questionnaire (PAR-Q). Individuals endorsing joint problems, prescription medication usage, or other medical conditions that could limit exercise will be required to obtain written physician consent to participate.
21 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heather M. Niemeier, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
The Miriam Hospital/The Warren Alpert Medical School of Brown U niversity
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Weight Control and Diabetes Research Center, The Miriam Hospital
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K23 DK73536-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.